000558 天府文旅 B004 000826 启迪环境 B001 000998 隆平高科 B001 001236 弘业期货 A07 001314 亿道信息 A06 001324 长青科技 A06 002037 保利联合 A06 002198 嘉应制药 A07 002219 新里程 B001 002330 得利斯 B007 002408 齐翔腾达 B003 002424 贵州百灵 A07 002600 领益智造 B007 002629 仁智股份 A07 002634 棒杰股份 A07 002716 湖南白银 A06 002775 文科股份 B004 002799 环球印务 A07 002921 联诚精密 A07 002940 昂利康 B004 002951 金时科技 A06 300691 联合光电 A06 301632 广东建科 A08 600009 上海机场 A08 600031 三一重工 A08 600104 上汽集团 A08 600166 福田汽车 B003 600507 方大特钢 B001 平安基金 B003 融通基金 B007 上银基金 B005 天弘基金 B006 太平基金 B005 信达证券基金 ...

Core Viewpoint - The major shareholder, Wukuang Jintong Equity Investment Fund Management Co., Ltd., and its concerted action party plan to reduce their holdings in New Mile Health Technology Group Co., Ltd. by up to 67,747,635 shares, representing 2% of the total share capital, within a three-month period starting from May 23, 2025 [1] Group 1: Shareholding Changes - Wukuang Jintong and its concerted action party reduced their holdings by 22,387,200 shares from July 14 to July 31, 2025, which is 0.6609% of the total share capital [2] - After the reduction, Wukuang Jintong holds 174,862,123 shares and Shenzhen Tongzhikang holds 62,250,677 shares, totaling 237,112,800 shares, which is 6.9999% of the total share capital [2] - The total shares held by Wukuang Jintong decreased from 259,500,000 shares (7.6608%) to 237,112,800 shares (6.9999%) [2] Group 2: Compliance and Legal Matters - The shareholding change does not violate any laws, regulations, or rules related to securities and corporate governance [3] - There are no shares that are restricted from voting rights according to the Securities Law [3]

Group 1 - The core point of the article is that Wuzhong Jintong Equity Investment Fund Management Co., Ltd. and its concerted actions plan to reduce their shareholding in the company by a total of 22.3872 million shares, which represents 0.66% of the company's total share capital [1] - After the reduction, the total shares held by the two parties will be 23.7128 million shares, decreasing their ownership stake to 6.9999% of the company's total share capital [1]

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2025-044 新里程健康科技集团股份有限公司 关于持股 5%以上股东权益变动触及 1%整数倍的公告 股东五矿金通股权投资基金管理有限公司－金通健康产业 1 号私募股权投资 基金及其一致行动人五矿金通股权投资基金管理有限公司－深圳通芝康健康产 业投资企业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"）于 2025 年 4 月 28 日披露了《关于持股 5%以上股东拟减持股份的预披露公告》（公 告编号：2025-010）。公司股东五矿金通股权投资基金管理有限公司－金通健康 产业 1 号私募股权投资基金（以下简称"五矿-金通健"）及其一致行动人五矿 金通股权投资基金管理有限公司－深圳通芝康健康产业投资企业（有限合伙）（以 下简称"五矿-通芝康"）拟在该公告披露日起十五个交易日后的三个月内（即 2025 年 5 月 23 日至 2025 年 8 月 22 ...

Overview of Guarantees - New Mileage Health Technology Group Co., Ltd. has approved a total guarantee amount of RMB 1.814 billion for its subsidiaries to apply for credit lines from financial institutions over the next 12 months [2] - The company has signed a maximum guarantee contract with Jiangsu Siyang Rural Commercial Bank for Siyang Hospital, providing a joint liability guarantee of up to RMB 29.5 million [2] - A similar guarantee contract has been signed with Jiujiang Bank for Ganzi Hospital, with a maximum guarantee amount not exceeding RMB 15 million [3] Basic Information of Guaranteed Entities - Siyang Hospital, established on May 5, 2017, has a registered capital of RMB 343.992 million and is a subsidiary in which the company holds 84.80% of the shares [4][5] - Ganzi Hospital, established on February 25, 2005, has a registered capital of RMB 18.75 million, and the company holds 84.83% of the shares [7][8] Financial Indicators - The financial data for Siyang Hospital for the year 2024 has been audited, while the first quarter of 2025 data is unaudited [6][9] - The financial data for Ganzi Hospital for the year 2024 has also been audited, with the first quarter of 2025 data being unaudited [9] Contractual Details - The guarantee for Siyang Hospital is valid for three years, with a total guarantee amount of RMB 29.5 million [10] - The guarantee for Ganzi Hospital is also valid for three years, with a total guarantee amount of RMB 15 million [10] Board of Directors' Opinion - Both Siyang Hospital and Ganzi Hospital are included in the company's consolidated financial statements, and their operational conditions are deemed good [11] - The guarantees provided are expected to meet the funding needs for the business development of both hospitals, ensuring their sustainable and stable growth [11] Cumulative External Guarantee Situation - As of June 30, 2025, the actual guarantee balance for the company's subsidiaries is RMB 702.4665 million, accounting for 35.39% of the latest audited net assets [11]

Summary of Key Points Core Viewpoint - The company, New Mile Health Technology Group Co., Ltd., has approved a total guarantee amount of RMB 1.814 billion for its subsidiaries to secure credit facilities from financial institutions over the next 12 months [2][3]. Group 1: Guarantee Overview - The company held a board meeting on April 28, 2025, and a shareholder meeting on May 19, 2025, to approve the guarantee for its subsidiaries [2]. - The total guarantee amount approved is RMB 181,400 million [2]. - The company has provided joint liability guarantees for its subsidiaries, including Siyang Hospital and Ganxi Hospital, to secure loans from local banks [3][4]. Group 2: Financial Status of Guaranteed Entities - Siyang Hospital has a registered capital of RMB 343.992 million and is a wholly-owned subsidiary of the company, holding 84.80% of its shares [4][6]. - As of March 31, 2025, Siyang Hospital's total assets were RMB 972.998 million, with total liabilities of RMB 876.711 million [5]. - Ganxi Hospital, another subsidiary, has a registered capital of RMB 18.75 million and is also a controlled subsidiary, with the company holding 84.83% of its shares [6][7]. Group 3: Guarantee Contracts - The company has signed a maximum guarantee contract with Siyang Rural Commercial Bank for a loan amount of RMB 29.5 million for Siyang Hospital [7]. - A similar guarantee contract has been signed with Jiujiang Bank for a maximum amount of RMB 15 million for Ganxi Hospital [7]. - The guarantee period for both contracts is set for three years [7]. Group 4: Board Opinion and Risk Management - The board believes that both Siyang Hospital and Ganxi Hospital are operating well, and the company can fully manage their financial conditions [8]. - The financial risks associated with the guarantees are considered manageable and will not harm the interests of the company and its shareholders [8]. - As of June 30, 2025, the total actual guarantee balance for subsidiaries was RMB 702.4665 million, accounting for 35.39% of the company's latest audited net assets [9].

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2025-045 新里程健康科技集团股份有限公司 关于为下属医院提供担保的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示：公司本次被担保对象泗阳医院资产负债率超过70%，敬请投资者 关注担保风险。 一、担保情况概述 新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"）于 2025 年 4 月 28 日召开第六届董事会第三十三次会议，2025 年 5 月 19 日召开 2024 年 年度股东大会，审议通过了《关于为子公司提供担保额度预计的议案》，同意公 司为相关子公司未来 12 个月向相关合作银行等金融机构申请综合授信额度提供 连带责任担保，额度总计为人民币 181,400 万元（具体内容详见公司于 2025 年 4 月 29 日在巨潮资讯网上披露的《关于为子公司提供担保额度预计的公告》，公 告编号：2025-018）。 鉴于前期泗阳县人民医院有限公司（以下简称"泗阳医院"）与江苏泗阳农 村商业银行股份有限公司（以下简称"泗阳农商行"）签署的《流动资金循 ...

智通财经APP获悉，七牛智能(02567)早盘涨超9%，截至发稿，涨7.83%，报1.24港元，成交额287.78万 港元。 消息面上，2025年7月，得益于在行业内较早上线MCP功能，并针对用户需求提供多个模型效果的中立 对比，七牛智能AI大模型用户量突破10000人，验证了其技术路线的市场吸引力，也标志着公司换道AI 战略布局迎来新里程碑。 智通财经APP在《换道AI后，看七牛智能（02567）领涨48.8%背后的战略升维》中指出，自上市以来， 七牛智能便一直积极围绕AI展开战略布局，正式换道AI。如今，公司已蜕变成为"音视频+AI+云服 务"赛道的领先者。在AI产业爆发前夜，凭借音视频+AI+云服务的三重基因，七牛智能有望站在新一轮 技术革命的前沿。 ...

七牛智能(02567)早盘涨超9%，截至发稿，涨7.83%，报1.24港元，成交额287.78万港元。 智通财经APP在《换道AI后，看七牛智能(02567)领涨48.8%背后的战略升维》中指出，自上市以来，七 牛智能便一直积极围绕AI展开战略布局，正式换道AI。如今，公司已蜕变成为"音视频+AI+云服务"赛 道的领先者。在AI产业爆发前夜，凭借音视频+AI+云服务的三重基因，七牛智能有望站在新一轮技术 革命的前沿。 消息面上，2025年7月，得益于在行业内较早上线MCP功能，并针对用户需求提供多个模型效果的中立 对比，七牛智能AI大模型用户量突破10000人，验证了其技术路线的市场吸引力，也标志着公司换道AI 战略布局迎来新里程（002219）碑。 ...

Core Viewpoint - GAC Trumpchi has achieved a significant milestone by producing its 800,000th MPV, setting a new record for Chinese brands in the MPV segment, and marking the 450,000th unit of the Trumpchi M8 family, which has become the best-selling luxury MPV in China [1][3][6]. Group 1: Market Position and Product Development - The Trumpchi M8 was launched in 2017, entering a competitive high-end MPV market dominated by brands like Buick and Honda, where few Chinese models could exceed a price of 200,000 yuan [3][4]. - The M8 quickly gained popularity, selling over 1,000 units in its first month and establishing itself as a leader in the Chinese brand MPV market, with cumulative sales reaching nearly 450,000 units by July 2025 [3][4]. - Trumpchi has diversified its MPV offerings, covering a price range from 100,000 to 400,000 yuan, catering to various consumer needs from family to business use [4][6]. Group 2: Quality and Innovation - Trumpchi is recognized as a "Chinese MPV expert," with nearly 800,000 MPVs sold, reflecting its commitment to quality and innovation in the MPV market [6][12]. - The company has invested over 50 billion yuan in R&D, employing nearly 5,000 experts to develop advanced manufacturing capabilities and a comprehensive quality management system [11][12]. - The introduction of the "QDR" quality management system ensures high quality throughout the vehicle's lifecycle, from production to post-sale service [11][12]. Group 3: Technological Advancements - The newly launched Trumpchi M8 Hongmeng version features Huawei's Hongmeng cockpit, enhancing the smart interaction experience with zero learning curve and real-time voice control [14][15]. - The M8 series incorporates cutting-edge safety features, including a battery system with multiple safety protections and real-time monitoring, significantly improving safety standards [18]. - Collaborations with technology leaders like Huawei and CATL have enabled Trumpchi to integrate advanced technologies into its vehicles, positioning itself as a leader in smart MPVs [15][18]. Group 4: Market Strategy and Future Outlook - Trumpchi's focus on understanding user needs and maintaining high product quality is seen as a key factor in its competitive advantage and transition towards becoming a technology-driven enterprise [12][14]. - The company aims to solidify its market leadership in the MPV segment while evolving into a "smart MPV expert," reflecting a broader trend in the automotive industry towards electrification and advanced technology [15][18].